Treatment of epilepsy with third-line antiepileptic drugs. Felbamate, tiagabine, and sulthiame;Epilepsietherapie mit antiepileptika der dritten wahl. Felbamat, tiagabin und sultiam

Nervenarzt

Volumn 78, Issue 12, 2007, Pages 1407-1412

  Chahem, J ^a   Bauer, J ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Antiepileptic drugs; Epilepsy; Felbamate; Sulthiame; Tiagabine

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; FELBAMATE; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; SULTIAME; TIAGABINE; TOPIRAMATE;

ADD ON THERAPY; ADULT; ARTICLE; ATAXIA; ATTENTION DISTURBANCE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; DYSPNEA; EPILEPSY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; RETROSPECTIVE STUDY; SIDE EFFECT; WALKING DIFFICULTY; WEIGHT REDUCTION;

ADULT; ANTICONVULSANTS; EPILEPSY; HUMANS; NIPECOTIC ACIDS; PHENYLCARBAMATES; PROPYLENE GLYCOLS; RETROSPECTIVE STUDIES; THIAZINES; TREATMENT OUTCOME;

EID: 36649037657     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-007-2302-4     Document Type: Article

References (16)

1. Bauer J, Stawowy B, Lenders T et al. (1995) Efficacy and tolerability of tiagabine: Results of an add-on study in patients with refractory partial seizures. J Epilepsy 8: 83-86
2. Bauer J, Bergmann A, Reuber M et al. (2002) Tolerability of tiagabine: a prospective open-label study. Epileptic Disord 4: 257-260
3. Ben-Zeev B, Watemberg N, Lerman P et al. (2004) Sulthiame in childhood epilepsy. Pediatr Int 46: 521-524
4. Brodie MJ, Kwan P (2002) Staged approach to epilepsy management. Neurology [Suppl 5] 58: S2-S8
5. Canger R, Vignoli A, Bonardi R, Guidolin L (1999) Felbamate in refractory partial epilepsy. Epilepsy Res 34: 43-48
6. Crawford P, Meinardi H, Brown S et al. (2001) Tiagabine: efficacy and safety in adjunctive treatment of partial seizures. Epilepsia 42: 531-538
7. Jensen PK (1993) Felbamate in the treatment of refractory partial onset seizures. Epilepsia [Suppl 7] 34: 25-29
8. Koepp MJ, Patsalos PN, Sander JW (2002) Sulthiame in adults with refractory epilepsy and learning disability: an open trials. Epilepsy Res 50: 277-282
9. Koepp MJ, Edwards M, Collins J et al. (2005) Status epilepticus and tiagabine therapy revisited. Epilepsia 46: 1625-1632
10. Kramer U, Shahar E, Zelnik N et al. (2002) Carbamazepin vs. sulthiame in treating benign childhood epilepsy with centrotemporal spikes. J Child Neurol 17: 914-916
11. Lassen LC (1994) Phase II study of of tiagabine: efficacy and safety in adjunctive treatment of partial seizures. Novo Nordisk Clinical Study Report TIA-103/CNS/1, October 18, 1994
12. Leppik IE, Dreifuss FE, Pledger GW et al. (1991) Felbamate for partial seizures: results of a controlled clinical trial. Neurology 41: 1785-1789
13. Li LM, Nashef L, Moriarty J et al. (1996) Felbamate as add-on therapy. Eur Neurol 36: 146-148
14. McKee P (2004) Treating refractory epilepsy with tiagabine: clinical experience. Seizure 13: 478-480
15. Pellock JM, Faught E, Leppik IE et al. (2006) Felbamate: Consensus of current clinical experience. Epilepsy Res 71: 89-101
16. Rowan AJ, Uthman B, Ahmann P et al. (1994) Safety and efficacy of three dose levels of tiagabine HCl versus placebo as adjunctive treatment for complex partial seizures. Epilepsia [Suppl 8] 35: 54